CLD-01

N/A

Report date: 2025/01/26 18:58:53

Base Information

Drug NameCLD-01
Drug Alias Nameattenuated vaccinia virus + autologous stem cells (Calidi Biotherapeutics)oncolytic vaccinia virus therapy delivered via autologous stem cells (Calidi Biotherapeutics)oncolytic virus-based immunotherapy (Calidi Biotherapeutics)ACAM-2000/SVF (Calidi Biotherapeutics)CLD-01
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalidi Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalidi Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsTriple Negative Breast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A